XTL Biopharmaceuticals Ltd. (TLV:XTLB)
Israel
· Delayed Price · Currency is ILS · Price in ILA 3.000
0.00 (0.00%)
Dec 4, 2025, 4:41 PM IDT
XTL Biopharmaceuticals Revenue
In the year 2024, XTL Biopharmaceuticals had annual revenue of $451.00K USD. XTL Biopharmaceuticals had revenue of $405.00K in the quarter ending December 31, 2024.
Revenue
$451.00K
Revenue Growth
n/a
P/S Ratio
16.10
Revenue / Employee
$45.10K
Employees
10
Market Cap
26.44M ILS
Revenue Chart
* This company reports financials in USD.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Teva Pharmaceutical Industries | 55.55B |
| Danel (Adir Yeoshua) | 2.87B |
| Kamada | 578.74M |
| BrainsWay | 162.56M |
| SofWave Medical | 255.13M |
| Bait Bakfar | 107.78M |
| Ilex Medical | 915.05M |
| Novolog (Pharm-Up 1966) | 1.97B |